Batavia Biosciences is a global CDMO, specialising in the development and manufacturing of viral vectors, vaccines, and recombinant proteins. Their advanced services support biopharmaceutical companies in the translation of innovative therapies from research to clinic.

With a focus on viral vector-based therapeutics and oncolytic virus development, Batavia offers tailored process development and manufacturing solutions. They provide clinical and commercial manufacturing services to bring new biologics to market faster, ensuring high yields, reduced risks, and well-managed timelines.

Key Products and Services

• Viral vectors for gene therapy
• Viral vaccine production
• Oncolytic viruses for cancer therapies
• Process development for biologics
• GMP manufacturing for clinical and commercial stages

Batavia Biosciences continues to support the biopharmaceutical industry by accelerating the development of next-generation therapeutics, helping bring life-saving innovations to patients around the world.